Cargando…
CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap
Chimeric antigen receptor (CAR-T) therapy has marked a paradigm shift in the treatment of hematological malignancies and represent a promising growing field also in solid tumors. Neurotoxicity is a well‐recognized common complication of CAR-T therapy and is at the forefront of concerns for CAR-based...
Autores principales: | Gatto, Lidia, Ricciotti, Ilaria, Tosoni, Alicia, Di Nunno, Vincenzo, Bartolini, Stefania, Ranieri, Lucia, Franceschi, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312075/ https://www.ncbi.nlm.nih.gov/pubmed/37397356 http://dx.doi.org/10.3389/fonc.2023.1206983 |
Ejemplares similares
-
DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open
por: Gatto, Lidia, et al.
Publicado: (2023) -
Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?
por: Di Nunno, Vincenzo, et al.
Publicado: (2023) -
Olfactory neuroblastoma: diagnosis, management, and current treatment options
por: Tosoni, Alicia, et al.
Publicado: (2023) -
Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution
por: Di Nunno, Vincenzo, et al.
Publicado: (2023) -
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
por: Gatto, Lidia, et al.
Publicado: (2022)